lumasiran
Showing 1 - 3 of 3
PH1, Primary Hyperoxaluria, RNAi Therapeutic Trial in Worldwide (Lumasiran)
Active, not recruiting
- PH1
- +4 more
- Lumasiran
-
Bordeaux, France
- +8 more
Jan 13, 2023
Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Placebo, Lumasiran)
Active, not recruiting
- Primary Hyperoxaluria Type 1 (PH1)
- Placebo
- Lumasiran
-
San Diego, California
- +15 more
Mar 4, 2022
Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Lumasiran, Placebo)
Completed
- Primary Hyperoxaluria Type 1 (PH1)
- Lumasiran
- Placebo
-
Bordeaux, France
- +8 more
Jan 22, 2020